These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Over-the-counter sales of statins and other drugs for asymptomatic conditions. Tinetti ME N Engl J Med; 2008 Jun; 358(25):2728-32. PubMed ID: 18565867 [No Abstract] [Full Text] [Related]
7. Prescription-equivalent over-the-counter drugs for allergy, heartburn, and cholesterol reduction. Curtiss FR J Manag Care Pharm; 2005; 11(1):94-6. PubMed ID: 15667239 [No Abstract] [Full Text] [Related]
8. The Food and Drug Administration and over-the-counter statins: an opportunity lost? Pickering TG J Clin Hypertens (Greenwich); 2008 Mar; 10(3):245-8. PubMed ID: 18326969 [No Abstract] [Full Text] [Related]
9. Is it appropriate to make statins available over the counter? Over-the-counter statins are worth considering in primary prevention of cardiovascular disease. Gotto AM Circulation; 2006 Sep; 114(12):1310-4; discussion 1314. PubMed ID: 16982952 [No Abstract] [Full Text] [Related]
10. Over-the-counter statins. Malik NN Lancet; 2004 Jul 31-Aug 6; 364(9432):411. PubMed ID: 15288726 [No Abstract] [Full Text] [Related]
11. A cost-effectiveness analysis of over-the-counter statins. Stomberg C; Albaugh M; Shiffman S; Sood N Am J Manag Care; 2016 May; 22(5):e294-303. PubMed ID: 27266585 [TBL] [Abstract][Full Text] [Related]
16. Torcetrapib and atorvastatin--should marketing drive the research agenda? Avorn J N Engl J Med; 2005 Jun; 352(25):2573-6. PubMed ID: 15972861 [No Abstract] [Full Text] [Related]
17. Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins. Barter PJ; Rye KA Circulation; 2006 Sep; 114(12):1315-20; discussion 1320. PubMed ID: 16982953 [No Abstract] [Full Text] [Related]
18. The dangers of self-dosing. Schultz S US News World Rep; 1998 Jul; 125(2):58. PubMed ID: 10181369 [No Abstract] [Full Text] [Related]
19. Over-the-counter statins and cardiovascular disease prevention: perspectives, challenges, and opportunities. Gotto AM Clin Pharmacol Ther; 2005 Sep; 78(3):213-7. PubMed ID: 16153391 [No Abstract] [Full Text] [Related]